跳转至内容
Merck
所有图片(1)

文件

740063

Sigma-Aldrich

壳聚糖

high purity, Mv 60,000-120,000

别名:

KiOmedine-CsU® B, 聚（D-氨基葡萄糖）, 脱乙酰几丁质

登录查看公司和协议定价
所有图片(1)

About This Item

CAS号:
9012-76-4
MDL號碼:
MFCD00161512
分類程式碼代碼:
12352201

生物源

white mushroom

等級

high purity

分子量

Mv 60,000-120,000

成份

Bacterial endotoxins, ≤10 EU/g
Beta-glucan, ≤5 % (w/w)
Chitosan, ≥93 % (w/w)
Proteins, ≤1 % (w/w)

黏度

5-200 mPa.s (1% solution in 1% HAc)

溶解度

acetic acid: 1% (solution)

儲存溫度

2-8°C

InChI

1S/C56H103N9O39/c1-87-56(86)65-28-38(84)46(19(10-74)96-55(28)104-45-18(9-73)95-49(27(64)37(45)83)97-39-12(3-67)88-47(85)20(57)31(39)77)103-54-26(63)36(82)44(17(8-72)94-54)102-53-25(62)35(81)43(16(7-71)93-53)101-52-24(61)34(80)42(15(6-70)92-52)100-51-23(60)33(79)41(14(5-69)91-51)99-50-22(59)32(78)40(13(4-68)90-50)98-48-21(58)30(76)29(75)11(2-66)89-48/h11-55,66-85H,2-10,57-64H2,1H3,(H,65,86)/t11-,12-,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23-,24-,25-,26-,27-,28-,29-,30-,31-,32-,33-,34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,47-,48+,49+,50+,51+,52+,53+,54+,55+/m1/s1

InChI 密鑰

FLASNYPZGWUPSU-SICDJOISSA-N

正在寻找类似产品? 访问 产品对比指南

一般說明

KiOmedine-CsU® is an ultra-pure chitosan of non-animal origin, produced from white mushrooms (Agaricus bisporus), in accordance with cGMP.
The crystalline structure is in the alpha form. The linkage between glucosamine units is beta(1,4).

應用

与多价阴离子形成凝胶。 产生透明溶液，干燥后形成坚固、透明的薄膜。
Ideal for wound healing and hemostasis; biosurgery and ophthalmology; scaffold and cell therapy; and drug delivery and vaccines

特點和優勢

生物相容、抗菌和环保的聚电解质，其具有多种应用，包括水处理、色谱法、化妆品添加剂、抗微生物活性的纺织品处理、纺织品的新型纤维、照相纸、可生物降解的薄膜、生物医学装置、以及用于药物递送中控制释放的微胶囊植入物。

物理性質

乙酰化度: ≤40 mol. %

法律資訊

KitoZyme产品
KiOmedine is a registered trademark of KitoZyme, S.A.

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

nwg

閃點（°F）

Not applicable

閃點（°C）

Not applicable

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Chitosan-based Biomaterials."Innovative Polymers Engineered for Drug Delivery and Tissue Engineering
Wu G, et al.
Material Matters, 7(3) null
Alberto Busilacchi et al.
Carbohydrate polymers, 98(1), 665-676 (2013-08-31)
The idea of using chitosan as a functional delivery aid to support simultaneously PRP, stem cells and growth factors (GF) is associated with the intention to use morphogenic biomaterials to modulate the natural healing sequence in bone and other tissues.
Liming Hu et al.
Nanoscale, 5(8), 3103-3111 (2013-03-22)
Within the past few years, chitosan-based drug delivery vehicles have become some of the most attractive to be studied. In contrast to all other polysaccharides, chitosan has demonstrated its unique characteristics for drug delivery platforms, including its active primary amino
Electrochemical biosensor applications of polysaccharides chitin and chitosan.
Wipa Suginta et al.
Chemical reviews, 113(7), 5458-5479 (2013-04-06)
William D Stanish et al.
The Journal of bone and joint surgery. American volume, 95(18), 1640-1650 (2013-09-21)
Microfracture, the standard of care, is recognized to be an incomplete solution for cartilage damage. BST-CarGel, a chitosan-based medical device, is mixed with autologous whole blood and is applied to a microfractured cartilage lesion in which it physically stabilizes the
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门